El Paso Cancer Treatment Center
El Paso, Texas 79915
0 studies enrolling now · 9 studies all time
What they study most
Breast Cancer, Carcinoid Tumor, Carcinoma, Non-Small Cell Lung, Hormone Refractory Prostate Cancer, Lymphoma, T-Cell, Peripheral, Multiple Myeloma, Neuroendocrine Tumors, Peripheral T-cell Lymphoma, Prostate Cancer
Studies at this site
- A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma — Completed
- A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma — Completed
- Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer — Completed
- Evaluating E7389 in Patients With Hormone Refractory Prostate Cancer With Advanced and/or Metastatic Disease Stratified by Prior Chemotherapy — Completed
- A Phase II Study of E7389 in Patients With Breast Cancer, Previously Treated With Anthracycline, Taxane and Capecitabine — Completed
- Velcade,Thalidomide, and Dexamethasone Versus Velcade and Dexamethasone Versus Velcade, Melphalan, and Prednisone — Completed
- Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen — Completed
- Quarfloxin in Patients With Low to Intermediate Grade Neuroendocrine Carcinoma — Completed
- Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy — Stopped early